Platinum anticancer drugs, chemistry cisplatin

Recent reviews in the field of platinum anticancer drugs focus on platinum-nucleobase chemistry [7], biological processing of platinum-modified DNA [8], trans-platinum anticancer drugs [5], cisplatin and derived anticancer drugs [4,9], proteins and cisplatin [10], trans-diam-mineplatinum(II) and nucleic acids [11], and catalytic activity and DNA [12], just to mention a few. The aim of this review is to explore the chemistry in the interaction of various platinum compounds with nucleic... 

Rosenberg, B. Platinum Complexes for the Treatment of Cancer. Why the Search goes on. In Cisplatin Chemistry and Biochemistry of a Leading Anticancer Drug Lippert, B., Ed. Wiley-VCH New York, 1999 pp 3-30. 

N. Farrell, Y. Qu, U. Bierbach, M. Valsecchi, and E. Menta, Structure-activity Relationships Within Di-and Trinuclear Platinum Phase-I Clinical Anticancer Agents, in 30 Years of Cisplatin, Chemistry and Biochemistry of a Leading Anticancer Drug , ed. B. Lippert, Wiley VCH, Weinheim, 1999, p. 479. 

Rosenberg, B. (1999) Platinum complexes for the treatment of cancer why the search goes on Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug (Lip-pert, B. ed.) WUey-VCH, Basel, Switzerland, 3-27. 

---